TegoSens is developing a universally adoptable, non-invasive, and portable device that provides early actionable detection of direct lung tissue specific fluid levels in patients, driving guideline-based therapies for specific conditions such as heart failure. The TegoSens solution is extremely competitive, yet complementary to existing diagnostic offerings and addresses a significant unmet need for the management of patients at point of care and home.
In the News
Ikove and its portfolio of companies are making noise with groundbreaking innovation.
TegoSens: New Chair of Board of Directors
Our Portfolio of Companies Grown Into Successful Businesses
Check out the companies that Ikove Startup Nursery has founded.
AqueSource makes nanofiber-based products that deliver active compounds via edible, dissolvable strips, patches and implants.
speed reducer that allows for low-cost, compact, highly efficient, and ruggedized speed-reducing gear systems